BRCA1 and cancer: We propose that targeting systemic effects of the BRCA1 mutation carrier state that indirectly contribute to breast and Müllerian cancer risk elevation in such carriers is a potentially attractive approach toward the important goal of developing effective non-surgical means of cancer risk reduction in this population.